MIRM - Mirum Return on Sales by Net Profit

Brandmark of mirumpharma.com (MIRM)

Quarterly sales margins on GURU.Markets demonstrate how algorithmic drug discovery is optimizing internal processes at Mirum Pharmaceuticals (MIRM). This chart is complemented by a strategy of targeted acquisitions to expand the portfolio of rare pathologies. The value of -134.80 determines the latest valuation metric, highlighting stable superprofits from patent-protected lifelong therapies for pediatric cholestatic diseases.

mirumpharma.com (MIRM) Return on Sales by Net Profit: for the period 07/04/2022 - 11/20/2026

Analytical breakdowns for Mirum Pharma (MIRM)

- market value and analyst target forecast:
Summary company analytics:mirumpharma.com - MIRM
Manufactured product of Mirum Pharmaceuticals, Inc.

This metric is calculated as the ratio of net income to total revenue, determining the portion of each dollar of income remaining after covering all operating and tax expenses. For Mirum Pharmaceuticals (MIRM), the net profit margin reflects the commercialization efficiency of LIVMARLI, where high margins confirm the value of the patented therapy and the quality of cost management within the biotech sector.